Sinutab Sinus Allergy
2-[2-[4-[(4-Chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid
Drag to rotate; arrow keys step through the atoms. Structure from PubChem CID 2678.
Registration
- Applicants
- 1
- Registrations
- 3
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Johnson & Johnson (Pty) Ltd û East London | Sinutab sinus allergy | solution, effervescent | 350296, 350298, 410420 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Sinutab sinus allergy EACH TABLET CONTAINS CETIRIZINE DIHYDROCHLORIDE 10,0 mg | Not listed | 35029635/5.7.1/0296 | Registered | Not determined | None |
| Sinutab sinus allergy solution EACH 1,0 ml SOLUTION CONTAINS CETIRIZINE DIHYDROCHLORIDE 1,0 mg | Solution | 35029835/5.7.1/0298 | Registered | Not determined | None |
| Sinutab sinus allergy effervescent EACH EFFERVESCENT TABLET CONTAINS CETIRIZINE DIHYDROCHLORIDE 10,0 mg | Effervescent | 41042041/5.7.1/0420 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S1: Cetirizine
Consolidated Schedules 06 July 2026, line 318
5 of 11 approved products with this ingredient carry S2 on their leaflet.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Background
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.